ICAM-1 signaling in endothelial cells

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 22-32

  Lawson, Charlotte ^a   Wolf, Sabine ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Antibodies; Atherosclerosis; Cell signaling; Endothelial cells; Inflammation; Intercellular adhesion molecule 1; Soluble adhesion molecules; Trans endothelial migration

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; LEUKOCYTE MIGRATION; NONHUMAN; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 66949136652     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70004-0     Document Type: Conference Paper

References (102)

1. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J: Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a Rho-dependent pathway. J Immunol, 1999, 162, 2964-2973.
2. Aird WC: Endothelium in health and disease. Pharmacol Rep, 2008, 60, 139-143.
3. Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H et al.: Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol, 2002, 157, 1233-1245.
4. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol, 1991, 147, 4398-4401.
5. Becker JC, Termeer C, Schmidt RE, Brocker EB: Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol, 1993, 151, 7224-7232.
6. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J: Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 2001, 104, 1336-1342.
7. Bretscher A, Edwards K, Fehon RG: ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol, 2002, 3, 586-599.
8. Carman CV, Sage PT, Sciuto TE, de la Fuente MA, Geha RS, Ochs HD, Dvorak HF et al.: Transcellular diapedesis is initiated by invasive podosomes. Immunity, 2007, 26, 784-797.
9. Carman CV, Springer TA: A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol, 2004, 167, 377-388.
10. Carpen O, Pallai P, Staunton DE, Springer TA: Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J Cell Biol, 1992, 118, 1223-1234.
11. Champagne B, Tremblay P, Cantin A, St Pierre Y: Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol, 1998, 161, 6398-6405.
12. Couty JP, Rampon C, Leveque M, Laran-Chich MP, Bourdoulous S, Greenwood J, Couraud PO: PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J Neurochem, 2007, 103, 793-801.
13. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol, 1993, 171, 223-229.
14. Durieu-Trautmann O, Chaverot N, Cazaubon S, Strosberg AD, Couraud PO: Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem, 1994, 269, 12536-12540.
15. Etienne S, Adamson P, Greenwood J, Strosberg AD, Cazaubon S, Couraud PO: ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol, 1998, 161, 5755-57561.
16. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature, 2002, 420, 629-635.
17. Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO: ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol, 2000, 165, 3375-3383.
18. Federici C, Camoin L, Hattab M, Strosberg AD, Couraud PO: Association of the cytoplasmic domain of intercellular-adhesion molecule-1 with glyceraldehyde-3-phosphate dehydrogenase and beta-tubulin. Eur J Biochem, 1996, 238, 173-180.
19. Fonsatti E, Altomonte M, Coral S, Cattarossi I, Nicotra MR, Gasparollo A, Natali PG et al.: Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. Br J Cancer, 1997, 76, 1255-1261.
20. Gaetani E, Flex A, Pola R, Papaleo P, De Martini D, Pola E, Aloi F et al.: The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis, 2002, 13, 483-488.
21. Gaglia JL, Greenfield EA, Mattoo A, Sharpe AH, Freeman GJ, Kuchroo VK: Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. J Immunol, 2000, 165, 6091-6098.
22. Gearing AJ, Newman W: Circulating adhesion molecules in disease. Immunol Today, 1993, 14, 506-512.
23. Gho YS, Kleinman HK, Sosne G: Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res, 1999, 59, 5128-5132.
24. Giavazzi R, Chirivi RG, Garofalo A, Rambaldi A, Hemingway I, Pigott R, Gearing AJ: Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. Cancer Res, 1992, 52, 2628-2630.
25. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML: The immunological synapse: a molecular machine controlling T cell activation. Science, 1999, 285, 221-227.
26. Greenwood J, Amos CL, Walters CE, Couraud PO, Lyck R, Engelhardt B, Adamson P: Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol, 2003, 171, 2099-2108.
27. Greenwood J, Wang Y, Calder VL: Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology, 1995, 86, 408-415.
28. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME et al.: The major human rhinovirus receptor is ICAM-1. Cell, 1989, 56, 839-847.
29. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA et al.: Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol, 2002, 39, 1133-1138.
30. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol, 2006, 6, 508-519.
31. Heiska L, Alfthan K, Gronholm M, Vilja P, Vaheri A, Carpen O: Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4,5-bisphosphate. J Biol Chem, 1998, 273, 21893-21900.
32. Holder AL, Wolf S, Walshe C, Pandya P, Stanford RE, Smith JD, Rose ML et al.: Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol, 2008, 69, 71-78.
33. Holland J, Owens T: Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. The activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway. J Biol Chem, 1997, 272, 9108-9112.
34. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation, 1997, 96, 4219-4225.
35. Jiang H, Klein RM, Niederacher D, Du M, Marx R, Horlitz M, Boerrigter G et al.: C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction. Int J Cardiol, 2002, 84, 171-177.
36. Kitagawa K, Matsumoto M, Sasaki T, Hashimoto H, Kuwabara K, Ohtsuki T, Hori M: Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis, 2002, 160, 305-310.
37. Koyama Y, Tanaka Y, Saito K, Abe M, Nakatsuka K, Morimoto I, Auron PE et al.: Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription. J Immunol, 1996, 157, 5097-5103.
38. Labarrere CA, Nelson DR, Miller SJ, Nieto JM, Conner JA, Pitts DE, Kirlin PC et al.: Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, post-transplant ischemic events, and cardiac graft failure. Circulation, 2000, 102, 1549-1555.
39. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC: Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA, 1995, 92, 1505-1509.
40. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC: Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell, 1993, 73, 1423-1434.
41. Lawson C, Ainsworth M, Yacoub M, Rose M: Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J Immunol, 1999, 162, 2990-2996.
42. Lawson C, Ainsworth ME, McCormack AM, Yacoub M, Rose ML: Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: induction of VCAM-1 but no proliferation. Cardiovasc Res, 2001, 50, 547-555.
43. Lawson C, Holder AL, Stanford RE, Smith J, Rose ML: Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation, 2005, 80, 264-271.
44. Lee HM, Kim HJ, Won KJ, Choi WS, Lee KY, Bae YM, Park PJ et al.: Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells. Eur J Pharmacol, 2008, 579, 260-268.
45. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ et al.: E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 1992, 77, 543-549.
46. Lehmann JC, Jablonski-Westrich D, Haubold U, Gutierrez-Ramos JC, Springer T, Hamann A: Overlapping and selective roles of endothelial intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 in lymphocyte trafficking. J Immunol, 2003, 171, 2588-2593.
47. Leung KH: Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes. Biochem Biophys Res Commun, 1999, 260, 734-739.
48. Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol, 2007, 7, 678-689.
49. Linder S, Wintergerst U, Bender-Gotze C, Schwarz K, Pannicke U, Aepfelbacher M: Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype. Immunol Cell Biol, 2003, 81, 130-136.
50. Lub M, van Vliet SJ, Oomen SP, Pieters RA, Robinson M, Figdor CG, van Kooyk Y: Cytoplasmic tails of beta 1, beta 2, and beta 7 integrins differentially regulate LFA-1 function in K562 cells. Mol Biol Cell, 1997, 8, 719-728.
51. Lukacs NW, Strieter RM, Elner VM, Evanoff HL, Burdick M, Kunkel SL: Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood, 1994, 83, 1174-1178.
52. Lusis AJ: Atherosclerosis. Nature, 2000, 407, 233-241.
53. Lyck R, Reiss Y, Gerwin N, Greenwood J, Adamson P, Engelhardt B: T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood, 2003, 102, 3675-3683.
54. Lyons PD, Benveniste EN: Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia, 1998, 22, 103-112.
55. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L et al.: Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet, 2001, 358, 971-976.
56. Marlin SD, Springer TA, Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell, 1987, 51, 813-819.
57. Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ: A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature, 1990, 344, 70-72.
58. Martin S, Casasnovas JM, Staunton DE, Springer TA: Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/ immunoglobulin molecules. J Virol, 1993, 67, 3561-3568.
59. McCabe SM, Riddle L, Nakamura GR, Prashad H, Mehta A, Berman PW, Jardieu P: sICAM-1 enhances cytokine production stimulated by alloantigen. Cell Immunol, 1993, 150, 364-375.
60. Meyer DM, Dustin ML, Carron CP: Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol, 1995, 155, 3578-3584.
61. Mizia-Stec K: Cytokines and adhesive molecules in detection of endothelial dysfunction. Pharmacol Rep, 2006, 58, Suppl, 21-32.
62. Ockenhouse CF, Ho M, Tandon NN, van Seventer GA, Shaw S, White NJ, Jamieson GA et al.: Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis, 1991, 164, 163-169.
63. Oh HM, Lee S, Na BR, Wee H, Kim SH, Choi SC, Lee KM et al.: RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration. Mol Biol Cell, 2007, 18, 2322-2335.
64. Otto VI, Gloor SM, Frentzel S, Gilli U, Ammann E, Hein AE, Folkers G et al.: The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen-activated protein kinase. J Neurochem, 2002, 80, 824-834.
65. Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC, sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res, 2000, 60, 733-742.
66. Pigott R, Dillon LP, Hemingway IH, Gearing AJ: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun, 1992, 187, 584-589.
67. Pluskota E, Chen Y, D'Souza SE: Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival. J Biol Chem, 2000, 275, 30029-30036.
68. Pluskota E, D'Souza SE: Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur J Biochem, 2000, 267, 4693-4704.
69. Reiss Y, Engelhardt B: T cell interaction with ICAM-1-deficient endothelium in vitro: transendothelial migration of different T cell populations is mediated by endothelial ICAM-1 and ICAM-2. Int Immunol, 1999, 11, 1527-1539.
70. Ridker PM, Buring JE, Rifai N: Soluble P-selectin and the risk of future cardiovascular events. Circulation, 2001, 103, 491-495.
71. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 1998, 351, 88-92.
72. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K: Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol, 1995, 60, 9-15.
73. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med, 1999, 340, 115-126.
74. Ross R, Glomset J: Studies of primate arterial smooth muscle cells in relation to atherosclerosis. Adv Exp Med Biol, 1974, 43, 265-279.
75. Rothlein R, Kishimoto TK, Mainolfi E: Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J Immunol, 1994, 152, 2488-2495.
76. Sano H, Nakagawa N, Chiba R, Kurasawa K, Saito Y, Iwamoto I: Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem Biophys Res Commun, 1998, 250, 694-698.
77. Schmal H, Czermak BJ, Lentsch AB, Bless NM, Beck-Schimmer B, Friedl HP, Ward PA: Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol, 1998, 161, 3685-3693.
78. Schmid E, Muller TH, Budzinski RM, Binder K, Pfizenmaier K: Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J Interferon Cytokine Res, 1995, 15, 819-825.
79. Schwenke DC, Carew TE: Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis, 1989, 9, 895-907.
80. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC: Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest, 1989, 83, 2008-2017.
81. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 1994, 76, 301-314.
82. Stassen FR, Vainas T, Bruggeman CA: Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep, 2008, 60, 85-92.
83. Staunton DE, Dustin ML, Erickson HP, Springer TA: The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell, 1990, 61, 243-254.
84. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell, 1988, 52, 925-933.
85. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA: A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell, 1989, 56, 849-853.
86. Sultan S, Gosling M, Nagase H, Powell JT: Shear stress-induced shedding of soluble intercellular adhesion molecule-1 from saphenous vein endothelium. FEBS Lett, 2004, 564, 161-165.
87. Thompson PW, Randi AM, Ridley AJ: Intercellular adhesion molecule (ICAM)-1, but not ICAM-2, activates RhoA and stimulates c-fos and rhoA transcription in endothelial cells. J Immunol, 2002, 169, 1007-1013.
88. Tsakadze NL, Sen U, Zhao Z, Sithu SD, English WR, D'Souza SE: Signals mediating cleavage of intercellular adhesion molecule-1. Am J Physiol Cell Physiol, 2004, 287, C55-63.
89. Tsakadze NL, Zhao Z, D'Souza SE: Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc Med, 2002, 12, 101-108.
90. van Buul JD, Hordijk PL: Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol, 2004, 24, 824-833.
91. van de Stolpe A, van der Saag PT: Intercellular adhesion molecule-1. J Mol Med, 1996, 74, 13-33.
92. van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH: Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. Am J Cardiol, 2006, 97, 1697-1701.
93. van der Wal AC, Das PK, Tigges AJ, Becker AE: Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol, 1992, 141, 1427-1433.
94. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S: The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol, 1990, 144, 4579-4586.
95. Vestweber D: Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev, 2007, 218, 178-196.
96. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW: Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics, 1994, 21, 473-477.
97. Wakatsuki T, Kimura K, Kimura F, Shinomiya N, Ohtsubo M, Ishizawa M, Yamamoto M: A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell Adhes Commun, 1995, 3, 283-292.
98. Wallen NH, Held C, Rehnqvist N, Hjemdahl P: Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J, 1999, 20, 1039-1043.
99. Wang Q, Pfeiffer GR, 2nd, Gaarde WA: Activation of SRC tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells. J Biol Chem, 2003, 278, 47731-47743.
100. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol, 1995, 15, 551-561.
101. Wojciak-Stothard B, Williams L, Ridley AJ: Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. J Cell Biol, 1999, 145, 1293-1307.
102. Yang Y, Jun CD, Liu JH, Zhang R, Joachimiak A, Springer TA, Wang JH: Structural basis for dimerization of ICAM-1 on the cell surface. Mol Cell, 2004, 14, 269-276.